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Abstract:
Introduction/Objective:
To study in severe carotid atherosclerosis (CA): the frequency of mood disorders (MD); the impairment of quality of life (QoL); the
role of co-morbid MD in such impairment.
Methods:
Case-control study. Cases: consecutive in-patients with CA (stenosis ≥ 50%). Controls: subjects with no diagnosis of CA randomized
from  a  database  of  a  community  survey.  Psychiatric  diagnosis  according  to  DSM-IV  made  by  clinicians  and  semi-structured
interview, QoL measured by the Short Form Health Survey (SF-12).
Results:
This is the first study on comorbidity on CA disease and MD in which psychiatric diagnoses are conducted by clinicians according to
DSM-IV diagnostic criteria. Major Depressive Disorder (MDD) (17.4% vs 2.72%, P <0.0001) but not Bipolar Disorders (BD) (4.3%
vs  0.5%,  P  =  0.99)  was  higher  in  cases  (N=46)  than  in  controls  (N=  184).  SF-12  scores  in  cases  were  lower  than  in  controls
(30.56±8.12 vs 36.81±6:40; p <0.001) with QoL comparable to serious chronic diseases of the central nervous system. The burden of
a concomitant MDD or BD amplifies QoL impairment.
Conclusion:
Comorbid  MD aggravates  the  impairment  of  QoL  in  CA.  Unlike  autoimmune  diseases  or  degenerative  diseases  of  the  Central
Nervous System, CA shows a strong risk of MDD than BD.
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INTRODUCTION
Carotid atherosclerosis is a leading public health issue. The atherosclerotic disease has been the first cause of death
and morbidity in developed countries for the past decades, while recently the traditional risk factors for atherosclerotic
and cardiovascular diseases have increased also in some developing countries like China and India. It is estimated that
by 2020 cardiovascular diseases will be the major causes of morbidity and  mortality  also  in  most  developing  nations
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around the world [1]. Carotid atherosclerosis is a determinant of acute cerebrovascular events - e.g. stroke - and of early
cognitive impairment [2]. The incidence of stroke in the US is about 800,000 identified events each year [3, 4].
Approximately one out of 10 subjects over 70 years of age in the community presents with Carotid Stenosis. Many
of them are apparently asymptomatic, in the sense that these cases were not diagnosed for cardiovascular disease or
acute vascular events [5]; prevalence is twofold in subjects at risk [6]. Elderly age, male sex, history of vascular disease,
hypertension,  hypercholesterolemia,  metabolic  diseases  and  diabetes  mellitus,  and  history  of  smoking  have  been
identified as predictors of atherosclerosis [7]. This means that adequate preventive measures could be implemented and,
in the caseof already manifested and identified significative stenosis, an appropriate intervention could prevent cerebral
vascular attacks and stroke. In fact there are now standardized and safe enough methods to treat carotid stenosis: for
many years the gold standard has been a surgical treatment with carotid endarterectomy (CEA), sided in the past two
decades  by  endovascular  stenting  of  carotid  lesions  (CAS),  a  valid  alternative  [8,  9].  Both  treatments  have  shown
similar effectiveness [10].
Prevention programs have encountered implementation difficulties and the appropriate surgical intervention is not
well accepted by patients yet [11]. A better assessment of the damage caused by carotid atherosclerosis to the quality of
life of people suffering from it could be useful to estimate the weight and the importance of appropriate prevention
programs.
Another  remarkable  aspect  requiring  clarification  is  the  role  of  comorbid  depressive  and  mood  disorders  in
treatment compliance and in the impairment of quality of life. Around 20% of patients with stroke were found comorbid
with depression [12]. However all research on comorbidity of vascular (and cerebrovascular) diseases and depressive
disorders published to date for the identification of cases of depression have adopted a questionnaire like the Center for
Epidemiologic Studies Depression Scale (CES-D) [13] and not a structured clinical interview. The latter is considered
the best method by the international standards of research in psychiatry [14 - 20].
A correct estimate of such comorbidity is a critical issue, because some researchers have found that concomitant
depression is a determinant of poorer clinical outcomes, mortality, and risk of functional disabilities [21]. Coherently an
effective treatment of depression was found to be associated with a better course of coronary heart disease, patient’s
adherence to interventions, and a decrease in acute events [22].
Evidence  shows  that  the  co-morbidity  between  depression  and  atherosclerosis  can  occur  because  people  with
depression have a high risk of developing atherosclerosis and, vice versa, because people with atherosclerosis - and with
neuro-vascular diseases in particular - are at risk of depression [23]. A specific subtype of depression - called vascular
depression - is characterized by: 1) onset in late life; 2) hyperintensities at brain Magnetic Resonance Imaging (MRI);
3)  great  neuropsychological  impairment;  4)  poor  response  to  antidepressants  especially  when  brain  damage  is
associated with deficits in executive functioning [23, 24]. Despite the lively debate stimulated by this new diagnosis, so
far  researchers  have  not  made  an  agreement  on  the  diagnostic  criteria  of  Vascular  Depression.  This  concept  is
nevertheless  an  indicator  of  how  the  two  disorders  may  be  influencing  their  respective  evolutionary  paths  [23].
The purpose of this work is to study the items listed below through standardized psychiatric diagnosis conducted by
means of semi-structured interviews carried out by clinicians and a case control design:
1) The frequency of major depressive disorder and other mood disorders in severe carotid atherosclerosis and the
risk compared to healthy controls;
2) The impairment of quality of life in people with carotid atherosclerosis;
3) The role played by mood disorders in the impairment of quality of life in people with carotid atherosclerosis.
METHODS
Design: Case-control Study
Subjects
Cases (Table 1) were inpatients with Carotid Atherosclerosis of the Thoracic and Vascular Surgery Clinic of the
University Hospital of Cagliari, Italy, from July 2013 to May 2014.
The controls included subjects with no diagnosis of Carotid Atherosclerosis who were selected from a database used
for an epidemiological survey in Italy [25]. The selection of sex- age- and residence-matched controls from the 3498-
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subject database followed a randomized block design. A block was created for each case that included all eligible ages
(± 2 years) and sex-matched controls drawn from the database. Four individuals per block were extracted for each case
and were automatically excluded from the remaining blocks.
Psychiatric Diagnosis
The “Advanced Neuropsychiatric Tools and Assessment Schedule” (ANTAS) is a semi-structured clinical interview
derived from the Structured Clinical Interview for DSM Disorders, non-patient version (SCID/NP-DSM-IV). It allows
detecting  and  diagnosing  psychiatric  disorders  [26].  The  validity  and  reliability  of  the  diagnoses  derived  from the
ANTAS were tested against SCID. Agreement with SCID was found with mean Cohen’s K = 0.85 [25]. The interviews
were carried out by clinicians with at least of experience in psychiatry. Bipolar Spectrum Diosrders were screened by
means of the Mood Disorder Questionnaire, Italian version [27].
Table 1. Demographic characteristics of the study sample.
  Cases (46) Controls (184)
Age ( mean ± ds) 72.56±7.26 72.50±7.26
Gender
m
f
30 (65.2 %)
16 (34.8%)
120 (65,2% )
64 (34.8%)
Diagnosis of Carotid Atherosclerosis
The  diagnosis  of  carotid  stenosis  in  the  selected  cases  was  performed  through  clinical  examination,  including
Duplex ultrasound scanning of the epi-aortic trunks and Contrast Enhancement Computed Tomography (CECT) of the
neck [28]. We included subjects with documented stenosis ≥ 50%, using ECST criteria. In controls, the presence of
Carotid Atherosclerosis was excluded after a clinical interview and anamnesis, subjects with history of severe vascular
disease, severe hypertension and diabetes mellitus were also excluded from controls.
Measure of Quality of Life
In both cases and controls the subject’s perception of their quality of life was measured by means of the Short Form
Health Survey (SF-12) [29]. The SF-12 is widely used tool internationally; it measures the perception of quality of life
according to specific dimensions: physical activity, health problems inducing limitation of physical activities and roles,
emotional status, pain, general health, vitality, effectiveness of the social network, and mental health. The period of
reference for the scoring is one month prior to evaluation. Higher scores on the SF-12 are associated with a higher
quality of life.
Table 2. Quality of life and mood disorders in cases and controls.
  Cases (46) Controls (184) df P OR CI 95%
SF12 30.56±8.12 36.81±6.40 F(1,228,229)=31.325 p<0.000    
MDQ 6 (13.0%) 5 (2.76%) χ2=8.76 (1) p=0.003 5.43 1.38 -21.82
MDD Lifetime 8 (17.4%) 5 (2.72 % ) χ2=15.07 (1 ) p<0.0001 7.62 2.10 -28.66
Bipolar Disorder (BP1-BP2) 2 (4.3%) 1 (0.5%) 0.01 ( 2) p=0.99 ----  
1 df 2 with Yates’s correction
Analysis of Data and Measure of Attributable Burden in Worsening QoL
Comparison between means and standard deviations of SF-12 scores and other numerical data in the sample was
carried out by means of ANOVA one-way statistics. According to previous published papers [30, 31] “Attributable
Burden in Worsening QoL” means the difference between the SF-12 score of cases with Carotid Atherosclerosis and the
SF-12 score of an age- and sex-matched sample without the disorder and drawn from the Italian database community
survey  [25].  A  comparison  on  “Attributable  Burden  in  Worsening  QoL”  was  carried  out  comparing  Carotid
Athrosclerosis scores with other impairing health condition measures in studies that had drawn their controls from the
same data base used in the preset study for controls, and where all cases were consecutive cases referring to units of the
same University Hospital in the same city [30 - 34].
Ethical Aspects
The community survey and the program of a series of case controls on databank-based studies for controls were
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approved by the ethical committee of the Italian National Health Institute (Rome). This study protocol was approved by
the independent ethical committee of the Azienda Ospedaliero Universitaria of Cagliari, Italy. An informed consent
form was signed by each candidate. The study did not imply any change of the scheduled treatment for patients, which
is defined according to the clinical judgment and international guidelines and by the patients’ decision to accept the
treatment or not.
RESULTS
The sample of this research (see Table 1) consisted of 46 patients with carotid stenosis; it was composed of 30 men
(65.2%) and 16 women (34.8%). It included 8 (17.39%) patients with Transitory Ischemic Attack, 4 (8.70%) with slight
Stroke, 3 (6.52%) with a history of "drop-attack", and 31 (67.39%) with asymptomatic carotid disease.
The  control  group  consisted  of  184  subjects  without  a  diagnosis  of  carotid  stenosis,  selected  with  the  above-
described matching technique. This technique creates a sample of controls that is perfectly homogeneous with the study
cases in terms of gender and age variables.
Table  3.  Burden Attributable  to  Carotid  Atherosclerosis  in  worsening  quality  of  life  and comparison with  other  disease
(studies were carried out with controls drawn from the same community study data bank, and cases were consecutive ones in
wards of the same University Hospital).
Disorders
SF-12
(Mean±sd)
Attributable Burden
[Sf-12 in standardized
controls – SF-12 in cases]
Comparison with
Carotid atherosclerosis
Comparison with
Carotid atherosclerosis
With Major Mood Dis
Major Depressive Disorder 33.8 ±9.2 5.6±3.6 (N=287) DF 1,331,332; F= 0.978
p=0.32
Df 1,293,294; F=9.16 p=0.003
Multiple Sclerosis 29.5±7.3 7.0±3.5 (N=201) DF 1,245,246; F= 1.642
p=0.201
Df 1,209,210; F=3.50 p=0.062
Wilson’s Disease 33.8±9.0 4.4±1.7 (N=23) DF 1,67,68; F=2.80
p=0.099
Df 1,31,32; F=8.49 p=0.003
Eating Disorders 34.9±6.2 4.4±6.6 (N=60) DF 1,104,105; F= 2.374
p=0.126
Df 1,68,69; F=4.49 p=0.038
Panic Disorder 35.5±4.6 2.9±0.9 (N=123) DF 1,167,168; F=49.751
p<0.0001
DF 1,131,132 F=76.78
Panic Disorder with Agoraphobia 34.5±6.1 4.2±2.4 (N=32) DF 1,76,77; F=4.4
p=0.039
Df 1,40,42; F=10.92 p=0.002
Carotid Atherosclerosis 30.6±8.1 6.2±5.0 (N=46)    
Carotid Atherosclerosis with Major
Mood Disorders (DDM or BP)
27.2±5.2 9.30±7.8 (N=10)    
Cases show a lifetime prevalence of manic/hypomanic episodes measured as positive at the screening (MDQ score>
7) and higher than in controls (13.0% vs 2.76% P = 0.003). Regarding the prevalence of Bipolar Disorder (BP 1/BP 2
according to DSM-IV) the difference between cases and controls did not reach statistical significance (4.3% vs 0.5%, P
= 0.99) (Table 2).
The lifetime prevalence of Major Depressive Disorder, diagnosed according to DSM-IV criteria, was higher in cases
than in controls (17.4% vs 2.72%, P <0.0001). Among cases, out of the six patients with co-morbid major depressive
disorder four had had onset after the age of 60 (8.7%) as against one in the control group (0.5%).
The mean scores of  SF12 in patients  with carotid atherosclerosis  (cases)  were significantly lower than those of
healthy controls (30.56 ± 8:12 vs 36.81 ± 6:40; p <0.001) (see Table 2).
The  burden  attributable  to  carotid  atherosclerosis  in  worsening  quality  of  life  is  comparable  to  that  of  serious
chronic  diseases  of  the  central  nervous  system  such  as  Wilson’s  disease  and  Multiple  Sclerosis,  and  with  severe
psychiatric  disorders like Major Depressive Disorder (Table 3).  The burden of a concomitant  major mood disorder
(MDD or BD) amplifies quality of life impairment, patients with carotid atherosclerosis in comorbidity with a major
mood disorder have a greater impairment than those who have major depression (DF 1,293,294; F=9.16 P=0.003) end
ever than those with Wilson's disease (DF 1,31,32; F=8.49 p=0.003 (Table 3).
DISCUSSION
Our study found that carotid atherosclerosis is comorbid (lifetime) with Major Depressive Disorder in about 1 case
out 5 with an approximate risk is about 6 times higher than the standardized sample without atherosclerosis disease.
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This result is consistent with the prevalence of depression among patients with cerebrovascular disease or stroke, which
oscillates between 15 and 25% [12]. As underlined in the introduction of this study we must consider that the research
works carried out so far have adopted a questionnaire as the CES-D for the identification of cases of depression; they
did not use structured clinical interviews carried out by clinicians. The latter is considered the best method available for
psychiatric diagnosis in clinical patients ad in community epidemiological samples [35, 36]. The use of this method in
addition  to  screening  questionnaires  allows  identifying  “cases”  according  to  international  classification  systems  as
DSM-IV. The use of CES-D was common of those studies that have found an association between carotid disease and
depressive symptoms [15 - 20] as well as in the famous "Rotterdam Study" that did not find this association [14]. This
is therefore the first study on comorbidity between mood disorders and carotid vascular disease in which psychiatric
diagnoses  are  conducted  by  clinicians,  through  a  semi-structured  interview  and  in  accordance  with  international
diagnostic criteria. It is also the first study that allows a better approximation of the risk by means of a case-control
model.
Our sample did not show a risk of DSM-IV Bipolar I or II Disorder that would be similar to the risk found for DSM-
IV  MDD,  although  patients  with  hypomanic  episodes  attributable  to  the  bipolar  spectrum  -  as  measured  with  an
instrument like the MDQ – tend to have a greater risk in the presence of carotid atherosclerosis. A vast literature on the
association between vascular heart disease and bipolar disorder is available, often with a positive association ([37 - 39],
and sometimes with no association at all [40]. Data in the literature related to vascular brain diseases are rare, but an
association was proved by one study at least [41]. However the most important determinants of vascular disease such as
diabetes, alcohol abuse and smoking were found more frequently in bipolar patients than in healthy controls [42]. The
lack of homogeneity among the results  and the fact  that  an association between atherosclerotic disease and bipolar
disorder was not always found despite an increased presence of hypothetical risk factors in the studies, as in our case,
could be explained by bipolar disorders’  developing only belatedly vascular lesions [39].  Moreover the association
between vascular and cerebrovascular disease and bipolar disorder would drastically shorten life expectancy, generating
a bias in cross-sectional studies [41]. An alternative hypothesis is that the Bipolar Spectrum Disorders associated with
vascular disease can present with unusual symptoms. Our study found an association with the broad area of the bipolar
spectrum defined by positivity to MDQ, and not with the diagnosis of bipolar disorder according to DSM-IV. This
might be supportive of the second hypothesis.
The finding that carotid disease has a higher risk of major depression than the risk of bipolar disorders is opposite to
the finding on autoimmune diseases of the central nervous system like Multiple Sclerosis [43], or degenerative diseases
with a genetic basis like Wilson's disease [32].
The measure of the subjective perception of quality of life in a done disorder is a construct of relevance in todays
clinical  practice  and  for  public  health  issues,  the  subjective  quality  of  life  is  adopted  as  a  measure  of  outcome  in
diseases having a strong impact on the daily life of patients [44, 45]. Our study has detected that carotid atherosclerosis
compromises  quality  of  life  when compared to  people  who do not  have  it,  and  its  burden is  comparable  to  that  of
serious  chronic  diseases  of  the  central  nervous  system  such  as  the  aforementioned  Wilson’s  disease  and  Multiple
Sclerosis, and with severe psychiatric disorders like Major Depressive Disorder (Table 3). The burden of a concomitant
major  mood  disorder  (MDD  or  BD)  amplifies  quality  of  life  impairment  to  the  extent  that  people  with  carotid
atherosclerosis in comorbidity with a major mood disorder have a greater impairment, at a statistically significant level,
than those who have major depression only or a severe degenerative disease such as Wilson's disease. Only against
Multiple Sclerosis does the difference reach the limits of statistical significance, although carotid atherosclerosis shows
a greater impairment of quality of life still.
LIMITATIONS
The  diagnosis  of  Carotid  Atherosclerosis  in  the  selected  cases  was  made  by  clinicians  by  means  of  Doppler
ultrasound scanning and CECT scan. In contrast, community controls reported to the interviewing clinicians a diagnosis
of Carotid Atherosclerosis if they were aware of such a problem even if subjects with history of severe vascular disease,
severe hypertension and diabetes mellitus were also excluded from controls
The risk of false negatives in the group of controls thus quite exists, although the hypothetical false negatives among
the  control  group  would  reinforce  the  null  hypothesis  of  no  association  between  Mood  Disorders  and  Carotid
Atherosclerosis,  and  decrease  the  Attributable  Burden  to  Carotid  Atheroscleris  in  impairing  quality  of  life.  This
limitation therefore does not invalidate the results of the study, but we may only speculate that the association found
may be rounded downward.
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On the other hand the case-control design does not allow excluding the effect of Berkson’s bias.
CONCLUSION
Mood Disorders are associated with the carotid vascular disease with a tight fit. Unlike autoimmune diseases or
degenerative diseases of the Central Nervous System, carotid atherosclerosis shows a higher risk of MDD than of BD.
The combination with a mood disorder aggravates the impairment of quality of life to the extent that the attributable
burden to these diseases in comorbidity is higher than the impairment caused by major depression or Wilsons’s disease
only.
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